The RNF43 Polyclonal Antibody (PAC020361) is a key tool for researchers studying RNF43, a protein involved in the regulation of cell growth and signaling pathways. This antibody is raised in rabbits and exhibits high reactivity with human samples, making it a reliable option for Western blot applications. By binding specifically to the RNF43 protein, this antibody enables precise detection and analysis in a variety of cell types, making it a valuable asset for studies in molecular biology and cancer research.RNF43, a RING-type E3 ubiquitin ligase, plays a crucial role in controlling the Wnt signaling pathway, which is implicated in various cellular processes such as cell proliferation, differentiation, and stem cell maintenance.
Dysregulation of RNF43 has been linked to the development and progression of cancer, making it a promising target for therapeutic intervention. By understanding the mechanisms underlying RNF43 function, researchers can gain insights into potential strategies for targeted cancer therapies and personalized medicine approaches.
Antibody Name:
RNF43 Antibody (PACO20361)
Antibody SKU:
PACO20361
Size:
50ul
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:1000-1:2000, WB:1:200-1:1000
Species Reactivity:
Human
Immunogen:
Synthetic peptide of human RNF43
Form:
Liquid
Storage Buffer:
-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Purification Method:
Antigen affinity purification
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Gel: 6%SDS-PAGE, Lysate: 40 µg, Lane: Jurkat cells, Primary antibody: PACO20361(RNF43 Antibody) at dilution 1/300, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 30 seconds.
Background:
RNF43 (ring finger protein 43), also known as URCC or RNF124, is a 783 amino acid, single-pass type I membrane protein of the Endoplasmic reticulum and nuclear envelope that is thought to function as an E3 ubiquitin-protein ligase. Containing one RING-type zinc finger and existing as four alternatively spliced isoforms, RNF43 is expressed in fetal kidney and lung, as well as in cancers of the lung, colon and kidney. RNF43 functions as a cytotoxic T lymphocyte tumor antigen, and is therefore considered a target for cancer immunotherapy.
Synonyms:
ring finger protein 43
UniProt Protein Function:
RNF43: E3 ubiquitin-protein ligase that acts as a negative regulator of the Wnt signaling pathway by mediating the ubiquitination, endocytosis and subsequent degradation of Wnt receptor complex components Frizzled. Acts on both canonical and non-canonical Wnt signaling pathway. Acts as a tumor suppressor in the intestinal stem cell zone by inhibiting the Wnt signaling pathway, thereby resticting the size of the intestinal stem cell zone. Belongs to the ZNRF3 family. 4 isoforms of the human protein are produced by alternative splicing.Protein type: Ubiquitin ligase; Ligase; Ubiquitin conjugating system; EC 6.3.2.-; Membrane protein, integralChromosomal Location of Human Ortholog: 17q22Cellular Component: integral to plasma membrane; plasma membraneMolecular Function: frizzled binding; protein binding; ubiquitin-protein ligase activityBiological Process: negative regulation of Wnt receptor signaling pathway; protein ubiquitination; protein ubiquitination during ubiquitin-dependent protein catabolic process
UniProt Protein Details:
NCBI Summary:
The protein encoded by this gene is a RING-type E3 ubiquitin ligase and is predicted to contain a transmembrane domain, a protease-associated domain, an ectodomain, and a cytoplasmic RING domain. This protein is thought to negatively regulate Wnt signaling, and expression of this gene results in an increase in ubiquitination of frizzled receptors, an alteration in their subcellular distribution, resulting in reduced surface levels of these receptors. Mutations in this gene have been reported in multiple tumor cells, including colorectal and endometrial cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]